Skip to main content

Think You Can Make Some Quick Money On The Most Recent Suffering Of Africans?


Think again, at least if it involves some miniscule pharmaceutical company no one’s ever heard of on the brink of a major breakthrough vis-à-vis Ebola.

“News coverage of Ebola and Middle East Respiratory Syndrome (MERS) is likely to catch the interest of ‘pump and dump’ scammers looking to capitalize on fears of a potential pandemic,” said Gerri Walsh, Finra’s senior vice president for investor education, in a statement.

Finra Warns of Ebola Stock Scams [WSJ MoneyBeat blog]
Investment scammers busy pumping Ebola stocks amid panic [N.Y. Post]


Moody’s: You Can Count On Future Bailouts

Moody’s, is taking the recent financial crisis it may or may not have borne any responsibility for one respect.